FTC Clears Pfizer's $2.4B Capsugel Sale To KKR
The Federal Trade Commission on Friday greenlighted asset manager Kohlberg Kravis Roberts & Co. LP's $2.4 billion acquisition of Pfizer Inc.'s Capsugel drug delivery business....To view the full article, register now.
Already a subscriber? Click here to view full article